Prices delayed by at least 15 minutes | Print
VALNEVA (VLA)
VALNEVA SEThis share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generatefuture cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue fromproduct sales.
Address
FRA
Telephone
+33 022 8073710
Forecast key dates
Name | Key Date |
---|---|
Valneva SE Annual Report for 2024 | 2025-03-21T00:00:00 |
Valneva SE Fourth Quarter Earnings Conference Call for 2024 | 2025-03-20T10:00:00 |
Valneva SE Fourth Quarter Earnings Results for 2024 | 2025-03-20T00:00:00 |
Valneva SE Third Quarter Earnings Results for 2024 | 2024-11-07T00:00:00 |
Valneva SE Second Quarter Earnings Results for 2024 | 2024-08-13T00:00:00 |
Valneva SE Annual General Meeting for 2024 | 2024-06-26T00:00:00 |
Valneva SE First Quarter Earnings Results for 2024 | 2024-05-07T00:00:00 |
Previous key dates
Name | Key Date |
---|---|
H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference | 2024-03-26T13:30:00 |
Valneva SE Annual Report for 2023 | 2024-03-22T00:00:00 |
Valneva SE Fourth Quarter Earnings Conference Call for 2023 | 2024-03-20T10:00:00 |
Valneva SE Fourth Quarter Earnings Result for 2023 | 2024-03-20T00:00:00 |
Barclays 26th Annual Global Healthcare Conference | 2024-03-12T10:45:00 |
TD Cowen's 44th Annual Health Care Conference | 2024-03-04T11:10:00 |
Valneva SE Third Quarter Earnings Results for 2023 | 2023-11-09T00:00:00 |
Valneva SE Second Quarter Earnings Results for 2023 | 2023-08-10T00:00:00 |
Valneva SE Annual General Meeting for 2023 | 2023-06-21T00:00:00 |
Valneva SE First Quarter Earnings Results for 2023 | 2023-05-04T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.